我院辅助治疗药物临床使用管理模式的建立

发布时间：2018-05-19 22:00

本文选题：辅助治疗用药 + 临床使用　；参考：《中国药房》2017年25期

【摘要】：目的:规范辅助治疗药物的临床使用。方法:建立我院辅助治疗药物的临床使用管理模式,统计管理工作开展前后辅助治疗用药的销售金额及不合理用药情况,评估管理效果。结果:我院建立的辅助治疗药物的管理模式包括确定辅助治疗药物目录、建立管理制度并确立其使用基本原则;再借助各药物用量排名并充分利用循证医学证据等进行用药点评;制定辅助治疗药物不合理用药(超适应证、超剂量、超疗程)等情况的分类处置原则等。经过1年多的管理实践,我院辅助治疗药物使用日益规范,辅助治疗药物占全部药品销售金额由管理前(2014年8月-2015年7月)的20.90%降至管理后(2015年8月-2016年7月)的15.99%(降低约5%);与2015年8月比较,2016年8月在93个辅助治疗药物中有48个品种销售金额降幅超过15%,不合理用药现象明显减少。结论:我院建立的辅助治疗药物临床使用管理模式有效促进了临床合理用药、降低了医疗费用。
[Abstract]:Objective: to standardize the clinical use of adjuvant drugs. Methods: to establish the management model of clinical use of adjuvant drugs in our hospital, and to evaluate the effect of management. Results: the management model of adjuvant therapy drugs established in our hospital included determining the catalogue of adjuvant treatment drugs, establishing the management system and establishing the basic principles of its use. Then with the help of the ranking of drug dosage and the full use of evidence-based medical evidence to make drug evaluation; to formulate the auxiliary treatment of irrational use of drugs (indications, overdose, excessive treatment) and other circumstances of the classification of disposal principles, and so on. After more than one year of management practice, the use of adjuvant drugs in our hospital has become increasingly standardized. Adjuvant treatment drugs accounted for 20.90% of total drug sales before administration (August 2014-July 2015) to 15.99 (about 5% lower) after administration (August 2015-July 2016); 93 adjuvant treatment drugs in August 2016 compared with August 2015 There are 48 varieties of sales of more than 15 decline, irrational drug use phenomenon significantly reduced. Conclusion: the management mode of clinical use of adjuvant therapy drugs established in our hospital can effectively promote the rational use of drugs and reduce the medical expenses.
【作者单位】：山东省交通医院药学部;
【基金】：山东省交通科技创新计划“基于循证医学证据的辅助治疗药物管理系统的构建”(No.2016B61)
【分类号】：R95

【相似文献】